References
- Locasciulli A., Mieli-Vergani G., Uderzo C., et al. Chronic Liver Disease in children with leukemia in long-term remission. Cancer 1983; 52: 1080–1087
- Parker D., Bate C.M., Craft A.W., Graham-Pole J., Malpas J.S., Stannsfeld A.G. Liver damage in children with acute leukemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy. Cancer Chemother. Pharmacol. 1980; 4: 121–127
- Dahl M. G. C., Gregory M.M., Scheuer P.J. Methotrexate hepatotoxicity in psoriasis. Comparison of different dose regimens. Br. J. Med. 1972; 1: 654–656
- Menard D.B., Gisselbrecht C., Marty M., Reyes F., Dhumeaux D. Antineoplastic agents and the liver. Gastroenterology 1980; 78: 142–164
- Rautonen J., Siimes M.A. Elevated serum transaminase activity at diagnosis is associated with rapidly progressing disease in children with acute lymphoblastic leukemia. Cancer 1988; 61: 754–757
- Locasciulli A., Santamaria M., Masera G., et al. Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy. J. Med. Virol. 1985; 15: 29–33
- Locasciulli A., Mura R., Fraschini D., et al. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study. Haematologica 1992; 77: 49–53
- Vergani D., Locasciulli A., Masera G., et al. His-tological evidence of hepatitis B virus infection with negative serology in children with leukemia who developed chronic liver disease. Lancet 1982; 1: 361–364
- Locasciulli A., Alberti A., Rossetti F., et al. Acute and chronic hepatitis in childhood leukemia: a multicentrk study from the Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). Med. Ped. Oncol. 1985; 13: 203–206
- Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne nonA-nonB viral hepatitis genome. Science 1989; 244–359
- Shimizu Y.K., Weiner A.J., Rosenblatt J., et al. Early events in hepatitis C virus infection of chimpanzees. Proc. Natl. Acad. Sci. USA 1990; 87: 6441–6444
- Farci P., Alter H.J., Wong D., et al. A long-term study of hepatitis C virus replication in nonA, nonB hepatitis. N. Engl. J. Med. 1991; 325: 98–104
- Amadori S., Arcese W., Isacchi G., et al. Mitox-antrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia. J. Clin. Oncol. 1991; 9: 1210–1214
- Bennett J.H., Catovsky D., Daniel M., et al. Proposal for the classification of the acute leukemias. Br. J. Hae-matol. 1976; 33: 451–458
- Alberti A., Morsica G., Chemello L., et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697–698
- Henze G., Langermann H.J., Ritter J., Schellong G., Riehm H. Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: a report from the BFM Study Group. Hematol. Bluttransf. 1981; 26: 87–93
- Miller D.R., Leikin S., Albo V., et al. Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group report. Cancer Treat. Rep. 1980; 64: 381–392
- Sznol M., Ohnuma T., Holland J.F. Hepatic toxicity of drugs used for hematologic neoplasia. Semin. Liver Dis. 1987; 7: 237–256
- Rubin E. Iatrogenic hepatic injury. Hum. Pathol. 1980; 11: 312–331
- Locasciulli A., Uderzo C., Pirola A., Masera G., Port-Mann B., Alberti A. Pattern of 'liver disease following high-dose cytosine arabinoside (HDARAC) therapy in children with acute myeloid leukemia. Leukemia and Lymphoma 1990; 2: 229–233
- Carson J.A., Tuke P.W., Makris M., et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-contamined factor VIII concentrates. Lancet 1990; 336: 1022–1025
- Wright T.L. Etiology of Fulminant Hepatic Failure: is another virus involved?. Gastroenterology 1993; 104: 640–653